The drug known as TC-5619 failed to show enough evidence of effectiveness against inattentive-predominant ADHD. The Winston-Salem-based company said it will have to reduce its employee count to save money, but it did not announce how many jobs will be affected.

via ADHD drug from Targacept NASDAQ: TRGT disappoints, more layoffs planned – Greensboro – The Business Journal.